Scynexis (SCYX) Other Non-Current Assets (2013 - 2026)
Scynexis' (SCYX) quarterly Other Non-Current Assets came in at $109000.0 in Q1 2026, little changed YoY from $109000.0 in Q1 2025, and little changed on a QoQ basis from $109000.0 in Q4 2025.
Scynexis (SCYX) Other Non-Current Assets (2013 - 2026) Analysis & Trends
Scynexis (SCYX) has 14 years of Other Non-Current Assets data on file, last reported at $109000.0 in Q1 2026.
- Quarterly Other Non-Current Assets changed 0.0% year-over-year to $109000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $109000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $109000.0, changed 0.0% from the prior year.
- Other Non-Current Assets steadied at $109000.0 in Q1 2026, from $109000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $6.1 million in Q2 2022 to a low of $25000.0 in Q3 2023.
- A 5-year average of $1.4 million and a median of $163000.0 in 2023 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets soared 2228.44% — and 2023, when it tumbled 99.51%.
- Tracing SCYX's Other Non-Current Assets over 5 years: stood at $5.5 million in 2022, then slumped by 97.04% to $163000.0 in 2023, then sank by 33.13% to $109000.0 in 2024, then changed by 0.0% to $109000.0 in 2025, then changed by 0.0% to $109000.0 in 2026.
- The last three Other Non-Current Assets figures came in at $109000.0 (Q1 2026), $109000.0 (Q4 2025), and $109000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 56.35 Mn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 1.79 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 384.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 503.80 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 239.50 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 1.06 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 59.30 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 304.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | 13.00 Mn |
| 10 | Scynexis | 61.90 Mn | -52.80 Mn | - | 109,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 109,000.00 |
| Mar 31, 2026 | 109,000.00 |
| Dec 31, 2025 | 109,000.00 |
| Sep 30, 2025 | 109,000.00 |
| Jun 30, 2025 | 109,000.00 |
| Mar 31, 2025 | 109,000.00 |
| Dec 31, 2024 | 109,000.00 |
| Sep 30, 2024 | 109,000.00 |
| Jun 30, 2024 | 163,000.00 |
| Mar 31, 2024 | 163,000.00 |
| Dec 31, 2023 | 163,000.00 |
| Sep 30, 2023 | 25,000.00 |
| Jun 30, 2023 | 163,000.00 |
| Mar 31, 2023 | 163,000.00 |
| Dec 31, 2022 | 5.51 Mn |
| Sep 30, 2022 | 5.08 Mn |
| Jun 30, 2022 | 6.08 Mn |
| Mar 31, 2022 | 5.54 Mn |
| Dec 31, 2021 | 6.24 Mn |
| Sep 30, 2021 | 218,000.00 |